PubRank

Catherine Buffet

Author PubWeight™ 28.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: a randomized trial. Clin Gastroenterol Hepatol 2007 2.08
2 Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 2004 2.08
3 Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc 2010 1.91
4 Hereditary persistence of alpha-fetoprotein is due to both proximal and distal hepatocyte nuclear factor-1 site mutations. Gastroenterology 2004 1.65
5 GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol 2011 1.25
6 Pancreatic metastases: a multicentric study of 22 patients. Gastroenterol Clin Biol 2004 1.18
7 Interferon-alpha-induced hyperthyroidism: a three-stage evolution from silent thyroiditis towards Graves' disease. Eur J Endocrinol 2006 1.14
8 Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study. Gastrointest Endosc 2002 1.04
9 Imatinib mesylate-induced acute hepatitis with autoimmune features. Eur J Gastroenterol Hepatol 2006 1.01
10 Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma. Cancer Res 2007 0.99
11 Evolution and predictive factors of thyroid disorder due to interferon alpha in the treatment of hepatitis C. World J Gastroenterol 2009 0.95
12 Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease. Liver Int 2005 0.95
13 Liver diseases related to MDR3 (ABCB4) gene deficiency. Front Biosci (Landmark Ed) 2009 0.92
14 Endoscopic treatment of cholangiocarcinoma and carcinoma of the duodenal papilla by intraductal high-intensity US: Results of a pilot study. Gastrointest Endosc 2002 0.91
15 Hepatitis C virus infection in systemic lupus erythematosus: a case-control study. J Rheumatol 2003 0.88
16 Independent and opposite associations of trunk fat and leg fat with liver enzyme levels. Liver Int 2008 0.86
17 Pegylated interferon alpha-2a-associated life-threatening Evans' syndrome in a patient with chronic hepatitis C. J Infect 2004 0.85
18 Reliability, cost-effectiveness, and safety of reuse of ancillary devices for ERCP. Gastrointest Endosc 2004 0.85
19 Incidence of interferon alfa-induced depression in patients with chronic hepatitis C. Hepatology 2002 0.81
20 Solid adenoma with exclusive hepatocellular differentiation: a new variant among pancreatic benign neoplasms? Virchows Arch 2002 0.81
21 Visual loss during interferon-alpha therapy in hepatitis C virus infection. J Hepatol 2002 0.80
22 Refractory chylothorax in hepatic cirrhosis: successful treatment by transjugular intrahepatic portosystemic shunt. J Thorac Imaging 2002 0.80
23 [Osseous metaplasia in a colonic adenocarcinoma]. Gastroenterol Clin Biol 2003 0.79
24 [Association of Budd-Chiari syndrome and celiac disease]. Gastroenterol Clin Biol 2003 0.77
25 Multiple peritoneal calcifying fibrous tumors revealed by ischemic colitis. Ann Diagn Pathol 2007 0.76
26 Effects of biliary obstruction on the penetration of ciprofloxacin and cefotaxime. Eur J Gastroenterol Hepatol 2008 0.76
27 [Noninvasive markers of fibrosis: replacement for liver biopsy?]. Presse Med 2007 0.75
28 [The consensus on treatment of hepatitis C]. Presse Med 2002 0.75
29 [Spontaneous viral clearance in patients with acute hepatitis C]. Presse Med 2003 0.75
30 [Duodenal duplication revealed by acute pancreatitis: endoscopic treatment]. Gastroenterol Clin Biol 2007 0.75
31 [Groove pancreatitis: a rare segmental form of chronic pancreatitis]. Gastroenterol Clin Biol 2002 0.75
32 [Anticipate a cirrhosis without a hepatic biopsy in patients with hemochromatosis]. Presse Med 2003 0.75
33 [Obesity and increase in transaminase, a dangerous and obvious link]. Presse Med 2003 0.75
34 [Following treatment of common bile duct lithiasis by endoscopic sphincterotomy, should it be completed by cholecystectomy?]. Presse Med 2003 0.75
35 Lack of detection of novel nonsense mutations on exon 3 of hemochromatosis gene in patients with hepatic iron overload. J Hepatol 2004 0.75
36 [Chronic hepatitis B, advances in treatment]. Presse Med 2006 0.75
37 [Still's disease and intestinal pseudo-obstruction]. Gastroenterol Clin Biol 2004 0.75
38 [Segmental infarction of the greater omentum]. Presse Med 2008 0.75
39 [Fatal liver failure after hepatitis B reactivation following chemotherapy for lymphoma in a patient with only anti-HBc antibody and review of the literature]. Gastroenterol Clin Biol 2007 0.75
40 [Hemochromatosis in the age of genetics]. Presse Med 2007 0.75
41 [Clinical evaluation of a hyperferritinemia]. Presse Med 2012 0.75
42 [Factors predicting the disappearance of virus B replication markers following treatment with lamivudine]. Presse Med 2003 0.75
43 Assessment of prescription practices for serological tests for viral hepatitis B and C in the Greater Parisian area in 2002. Gastroenterol Clin Biol 2006 0.75
44 [Not Available]. Bull Acad Natl Med 2014 0.75